49 min listen
204 - Nicolas Vachicouras CEO: Neurotech Series, Neurosoft Bioelectronics - Bioelectronics and Ethics: The Debate Today
FromHeads Talk
204 - Nicolas Vachicouras CEO: Neurotech Series, Neurosoft Bioelectronics - Bioelectronics and Ethics: The Debate Today
FromHeads Talk
ratings:
Length:
30 minutes
Released:
Apr 12, 2024
Format:
Podcast episode
Description
Follow me to see #HeadsTalk Podcast Audiograms every Monday on LinkedInEpisode Title: ??Bioelectronics and Ethics: The Debate Today??In this episode of Heads Talk, a departure from our Fintech/Finfluencer Series, we engage in a conversation with Nicolas Vachicourasm, CEO of Neurosoft Bioelectronics, a company he co-founded in 2019. Aside from securing approximately $9M in funding, Nicolas played a pivotal role in establishing a medical-grade manufacturing line for neural implant production and initiating first-in-human studies in the USA in 2023.Episode titled around the ethics of BCIs and Neurotechnology, our discussion delves into fascinating territories. I anticipate continuing this dialogue with other CSuites in the field in the weeks ahead.Topics Covered:◽️Commercialisation of Neurotechnology Products (Europe and US)◽️Neurosoft Bioelectronics products and application◽️BCI Ethics and Regulations ◽️Neurotech Developments in the Last 2 Years◽️What Industry Leaders are Talking About◽️Real-World Case Study Examples Next week's guest announced on LinkedIn every Monday. Follow me to see. ABOUT THE HOSTHeads Talk #HeadsTalk #HeadsTalkPodcast #AFlyOnTheBoardroomWall #HTNeurotechSeriesSupport the showFollow, Support, Contact Heads Talk - A Fly On The Boardroom Wall LinkedIn Website Twitter Email at info@elainepringle.com
Released:
Apr 12, 2024
Format:
Podcast episode
Titles in the series (100)
003 - Tomas Romero COO: Wipro, How Corporates Are Likely To Emerge From The Covid-19 Crisis by Heads Talk